SUBSCRIBE
SUBSCRIBE
News   Business

Raptor Pharmaceutical Inc. Reports Financial Results for the Transition Period From September 1, 2012 to December 31, 2012

March 15, 2013 | 
1 min read

NOVATO, Calif., March 14, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq:RPTP), today reported financial results for its four month transition period from September 1, 2012 to December 31, 2012.

Earnings
MORE ON THIS TOPIC
Sangamo's headquarters in Silicon Valley
Gene therapy
Sangamo’s Stock Plummets as Pfizer Axes Hemophilia Gene Therapy Pact
January 2, 2025
 · 
2 min read
 · 
Nick Paul Taylor
Art collage, hands and falling coins in orange circle. Modern design of finance and business.
Venture Capitalists
To Attract VC Dollars in 2025, Biopharma Must Bring the Data: Pitchbook
December 23, 2024
 · 
2 min read
 · 
Annalee Armstrong
Doubtful businessman stands in front of a crossroad with road split in three different ways as arrows shows opposed courses. Business challenge, choosing a correct pathway. Difficult decision concept
Executive Appointments
After Month of Bad News, Applied Shuffles Leadership, Lays Out Uncertain Path for Rare Disease Drug
December 23, 2024
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Stubborn Layoff Trend Continues Across Biopharma in 2024
December 23, 2024
 · 
207 min read
 · 
BioSpace Editorial Staff